Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
RNA
Atrium Therapeutics, Inc.
NASDAQGS
Biotechnology
United States
$14.19
▼
-0.41 (-2.81%)
CLOSED
—
OPEN
$14.51
HIGH
$14.65
LOW
$14.01
PREV CLOSE
$14.60
VOLUME
167.8K
0.92x avg
BID / ASK
10.37 / 18.09
spr 7.72
MARKET CAP
$242.7M
DAY RANGE
$14.01
$14.65
P/E (TTM)
—
Fwd -1.8
EPS (TTM)
-5.44
DIV YIELD
—
52W HIGH
$16.77
-15.4%
52W LOW
$11.13
+27.5%
BETA
—
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$14.19
+0.00
(+0.00%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
RNA
$14.19
▼
-2.81%
Chart
Valuation
Financials
Peers
News
RNA · K 線技術分析（即時、可互動）
basic
pro
快速分析（2–5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，一般約 2 分鐘，上游壅塞時最長約 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
MIXED
132 BARS · -3.8% YOY
1-year price chart. Started at 14.75, currently 14.19, down 3.8 percent. Range 11.18 to 16.54 over 132 data points.
2026-02-27
$14.75 → $14.19 (-3.8%)
2026-09-04
§ Valuation
Loading § Valuation
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$28.94
WACC Used
+7.0%
Terminal g
+3.5%
判定: hold
· peers $28.94 (+104.0%)
同業:
AVXL
CYPH PE4
ELDN
IVVD
GLSI
TARA
ABOS
TNXP
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
PEERS
同業與產業對照
CALM
10 PEERS · FINNHUB
AVXL
CYPH
ELDN
IVVD
GLSI
TARA
ABOS
TNXP
KROS
950160.KQ
NEWS
近期新聞（過去 14 天）
CALM
9 HEADLINES · LAST 14 DAYS
Atrium Therapeutics to Participate in Upcoming Investor Conferences
PR Newswire · 2026-09-02
Can Atrium Therapeutics (RNA)’s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?
Insider Monkey · 2026-08-28
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire · 2026-08-20
Atrium Therapeutics Reports Second Quarter 2026 Financial Results
PR Newswire · 2026-08-13
Atrium Therapeutics Earns Another $15 Million Milestone Payment From Bristol Myers Squibb
MT Newswires · 2026-08-13
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
PR Newswire · 2026-08-13
Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls
The Fly · 2026-08-06
Atrium Therapeutics Says FDA Clears Phase 1/2 Trial of ATR 1072 in PRKAG2 Syndrome
MT Newswires · 2026-07-14